Cellular targeting is one way to actively target solely diseased tissue in the body is to know the nature of a receptor on the cell for which the drug will be targeted and then utilization of cell-specific ligands will allow the nanoparticle to bind specifically to the cell that has the complementary receptor.
Intracellular delivery enables efficient drug delivery into various types of cells and it is a long-term studied topic in modern biotechnology. It is a critical process in many cellular-level studies, such as cellular drug therapy, gene editing delivery, and a series of biomedical research applications.
Targeted Drug Delivery System:A targeted drug delivery system is a particular form of drug delivery where the drug is released specifically to its site of action and not to the target organs, tissues, or cells.
Drug Targeting and Design: Drug targeting can be defined as the ability of a drug molecule to accumulate in the target organ or tissue specifically, so that the concentration of the drug will be high at the disease, while in non-target organs and tissues, its concentration is low, preferably, below the certain minimal level so as to prevent any toxic effects. Drug targeting can control the non-specific toxic effect of conventional drug delivery.
Drug design is also known as rational drug design or simply rational design. It is a new process of producing new medications based on the knowledge of a biological target.
Title : Nanomaterial-mediated systemically-administered m-rna-based Gene therapy directed exclusively to cancer, resulting in eradication of implanted orthotopic tumors with no side effects
A C Matin, Stanford University, United States
Title : Mucoadhesive electrospun fibers in oral drug delivery
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Qualitative and quantitative measures of drugs’ placenta permeability - a chromatographic and computational approach
Anna Weronika Sobańska, Medical University of Lodz, Poland
Title : The signification of the blood-brain barrier to the transfer of essential and toxic mineral elements
Bartolome Ribas Ozonas, Royal National Academy of Pharmacy, Spain
Title : New excipient to formulate poorly soluble APIs
Rajendran Arunagiri, Eastman, United States
Title : Multi-detection of pharmaceutical contamination in environment
Andreia Freitas, INIAV and REQUIMTE, Portugal
Title : HDAC inhibitors with non-hydroxamate warhead
Franz Josef Meyer Almes, University of Applied Sciences, Germany
Title : The role of non-antibiotic drugs on the development of antibiotic resistance
Mujde Eryilmaz, Ankara University, Turkey
Title : Digital health: Education in clinical pharmacy and implementation in practice
Aysu selcuk, Ankara University, Turkey
Title : Pharmacovigilance – Important, current trends, challenges and opportunities
Gurpreet Singh, Freyr Lifesciences Limited, United Kingdom